SCHEMBL14411900

SCHEMBL14411900

COc1ccc2c(c1)C(C1CCNCC1)CN2C(=O)c1ccnc(Cl)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PROKR1 Q8TCW9 10/20 0.38
GFER P55789 1/20 0.38
CDK1 P06493 1/20 0.38
CDK2 P24941 1/20 0.38
CASP3 P42574 1/20 0.38
GSK3B P49841 1/20 0.38
CDK7 P50613 1/20 0.38
CDK9 P50750 1/20 0.38
CASP7 P55210 1/20 0.38
CDK12 Q9NYV4 1/20 0.38
NOS3 P29474 1/20 0.37
NOS1 P29475 1/20 0.37
NOS2 P35228 1/20 0.37
CHRNB2 P17787 2/20 0.36
CHRNB4 P30926 2/20 0.36
CHRNA3 P32297 2/20 0.36
CHRNA7 P36544 2/20 0.36
CHRNA4 P43681 2/20 0.36
HPGDS O60760 1/20 0.36
CCR8 P51685 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14411896 0.90 PROKR1 (0.41) PROKR1GFERNOS3NOS1NOS2
SCHEMBL14411899 0.84 GFER (0.39) PROKR1GFERNOS3NOS1NOS2
SCHEMBL14411887 0.81 MCHR1 (0.39) PROKR1GFERNOS3NOS1NOS2
SCHEMBL5445827 0.70 PROKR1 (0.43) PROKR1GFERTACR3KCNH2
SCHEMBL14411881 0.69 PROKR1 (0.42) PROKR1GFERTACR3MCHR1
SCHEMBL14411895 0.67 PROKR1 (0.42) PROKR1GFERTACR3MCHR1
SCHEMBL7492026 0.66 SIGMAR1 (0.54) PROKR1GFER
SCHEMBL20892510 0.63 HPGD (0.60) GFER
SCHEMBL4785414 0.63 CES2 (0.59)
SCHEMBL26655574 0.63 HTR2C (0.43) CHRNB2CHRNB4CHRNA3CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070225269-A1 Use of (3-(1-(3-Phenyl-Propenyl)-Piperidin-4-Yl)-2,3-Dihydro-Indol-1-Yl)-(Pyridin-4-Yl)-Methanonone Derivatives and Related Compounds as Insecticides SYNGENTA CROP PROTECTION, INC. 2007-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225269-A1 Use of (3-(1-(3-Phenyl-Propenyl)-Piperidin-4-Yl)-2,3-Dihydro-Indol-1-Yl)-(Pyridin-4-Yl)-Methanonone Derivatives and Related Compounds as Insecticides CHRM1, NPY1R, MRM1 PROKR1 518/4885GFER 2676/4885CDK1 918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.